Sense Neuro Diagnostics

About:

Sense Neuro Diagnostics is a developer of non-invasive medical devices for neurological conditions.

Website: https://senseneuro.com/

Twitter/X: SenseDx

Top Investors: National Science Foundation, U.S. Department of Defense, Queen City Angels, Amit Shanbhag, St. Elizabeth Healthcare

Description:

Sense Neuro Diagnostics is a medical technology company focused on improving outcomes for stroke and brain injury patients through technology innovations that enable faster detection and more effective triage. Sense is developing non-invasive technology to enable continuous, real-time brain injury monitoring as well as rapid detection of traumatic brain injury and important stroke subtypes—ischemic stroke with large vessel occlusion, ischemic stroke without large vessel occlusion, and intracerebral hemorrhage. Learn about the ongoing pivotal trial for continuous monitoring of intracranial hemorrhage, and successful first-in-human pilot study of triage technology to determine stroke subtype.

Total Funding Amount:

$14.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cincinnati, Ohio, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)senseneuro.com

Founders:

George Shaw, Joseph Clark, Matthew Flaherty, Opeolu Adeoye

Number of Employees:

1-10

Last Funding Date:

2023-03-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai